Skip to content
Screener

AtriCure ATRC Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
$166K-0.6%
Abbott logo
AbbottABT
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
AngioDynamics logo
AngioDynamicsANGO
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX

Other financials

Income statement

See full
Revenue$153.6M+12.8%
Gross profit$118.6M+16.9%
Operating income$9.7M+256%
Net income$9.0M+245%
EPS (diluted)$0.18+238%

Balance sheet

See full
Cash & equivalents$167.8M+42.4%
Total debt$75.5M-3.8%
Total equity$516.4M+11.2%
Total assets$676.6M+11.1%

Cash flow

See full
Operating cash flow$22.2M+2.7%
CapEx$3.8M+41.5%
Free cash flow$18.4M-2.8%

Valuation

See full
Market cap$2.12B+20.7%
Enterprise value$2.03B+18.1%
P/E812.8×
P/S3.7×+0.2×

Profitability

See full
Gross margin76.3%+1.6pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.3%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.1×0.0×
Current ratio4.2×+0.3×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: AtriCure’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 1:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001323885-26-000035
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Share-based compensation expense23,58621,001
Depreciation5,8126,034
Amortization of intangible assets4,7684,221
Amortization of deferred financing costs210239
Acquired in-process research and development expense5,000
Other non-cash adjustments1,177311
Changes in operating assets and liabilities:

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is AtriCure's amortization of capitalized software and acquired intangible assets?
AtriCure (ATRC) reported amortization of capitalized software and acquired intangible assets of $1.65M in Q2 2026.
How has AtriCure's amortization of capitalized software and acquired intangible assets changed year-over-year?
AtriCure's amortization of capitalized software and acquired intangible assets decreased by 21.8% year-over-year, from $2.11M to $1.65M.
What is the long-term trend for AtriCure's amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), AtriCure's amortization of capitalized software and acquired intangible assets has grown at a 30.5% compound annual growth rate (CAGR), from $2.91M to $8.44M.

Ask your AI about AtriCure's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude